MATERIALS AND METHODS
Bacterial strains. The strains used are stock cultures of this laboratory and were isolated from clinical specimens. Escherichia coli 58-161 Nalr (resistant to nalidixic acid) and W3110 Rifr (resistant to rifampin) were used as recipients for Sa resistance in conjugation experiments. E. coli C Rifr was used as a recipient of Sa resistance in transformation. Shigella flexneri JS-E15 Sulr (resistant to sulfanilamide) is a stock culture of this laboratory, whose determinant governing Sa resistance is located on the chromosome between his and str (streptomycin resistance) (12) . Derivatives ofE. coli K-12, J53 (met pro), J62 (his try pro), and CSH-2 (met) were used as the hosts of R plasmids for incompatibility testings.
R plasmids. Standard R plasmids for incompatibility testing were obtained from N. Datta, Royal Postgraduate Medical School, London. Rms3O6, a conjugative tetracycline (Tc)-resistant plasmid, was carried in E. coli 58-161 Nalr and used to mobilize the transfer of the nonconjugative Sa plasmids.
Media. Brain heart infusion (BHI, Difco) broth was used for liquid cultures and for conjugal transfer of drug resistance. For the assay of Sa resistance and the selection of Sa-resistant transconjugants and transformants, a semisynthetic medium (S medium) was used, which consisted of 1,000 ml of medium A (4), 2 g of Casamino Acids (Difco), 10 mg of tryptophan, 1 mg of nicotinic acid, 10 mg of thiamine hydrochloride, and 2 g of glucose. Peptone-water (pH 7.2), used as a liquid culture for the determination of Sa resistance, consisted of 10 g of peptone, 5 g of sodium chloride, and 1,000 ml of distilled water. (S medium containing 1.2% of agar (S agar) was used for the determination of Sa resistance and for the selection of Sa-resistant transductants and transformants. S medium containing 1.0% lactose and 1.2% agar (SLac agar) was used for the slection of R+ transconjugants in incompatibility tests.
Determination of Sa resistance. An overnight peptone-water culture was diluted 100-fold with fresh peptone-water, and 1 loopful of diluted culture was inoculated on a series of S agar plates containing serial twofold dilutions of Sa. The minimum inhibitory concentration of drug was scored after 18 h of incubation at 370C.
Conjugal transfer of drug resistance. The conjugal transfer of drug resistance was followed by the method described previously (14) . Elimination of drug resistance. Each bacterial strain to be tested was inoculated in cooked-meat medium (Difco) at 37°C. After 18 h of incubation, the culture was kept in a cold room at 4°C for at least 4 weeks. The culture was then spread on an S agar plate, and the loss of Sa resistance was examined by the replica-plating method. Artificial elimination of Sa resistance was examined by inoculating each bacterial strain in peptone-water containing various concentrations of acriflavine. After incubation at 37°C for 18 h, the turbid culture that contained the maximum concentration of the drug was spread on an S-agar plate, and the loss of Sa resistance was examined by the replica-plating method.
Transformation of Sa resistance. The transformation procedure is essentially as described by Cohen et al. (2) . E. coli C Rifr was used as a recipient of Sa resistance. An overnight BHI broth culture of donor cells carrying an Sa plasmid (900 ml) was spun at 6,000 rpm for 15 min in a refrigerated centrifuge. The precipitate was washed once with Tris buffer [0.02 M tris (hydroxymethyl)aminomethane-0.02 M NaCl-1 mM ethylenediaminetetraacetate (pH 8.0)] and was used for the deoxy-VOL. 12, 1977 ribonucleic acid (DNA) preparation. The DNA preparation thus obtained was suspended in 2 ml of Tris buffer. E. coli C Rifr was grown overnight in BHI broth at 370C and used for the recipient. The recipient culture without the addition of the DNA preparation was used as a control.
Incompatibility experiments. Incompatibility experiments were carried out by the method described by Datta (3). E. coli C Rift strains carrying nonconjugative Sa plasmids were obtained by transformation with the plasmid DNAs obtained from the original Shigella and E. coli strains (see Table 4 ), and six strains were used as recipients for the transfer ofthe incompatibility standard plasmids. E. coli K-12 strains carrying the standard R plasmids were used as the donors. A 2-ml amount of a BHI culture of recipient cells and 0.5 ml of a donor BHI culture were mixed at the early stationary phase of growth. The mixed culture was incubated with gentle shaking at 37°C for 2 h, and appropriate dilutions were then spread on SLac agar containing 100 ,g of Sa per ml and 100 ,ug of rifampin per ml. Twenty colonies that grew on the plates after 48 h of incubation at 370C were cloned three times by using the same medium, and their drug resistance was examined. The stability of two plasmids coexisting in the same cell was examined after subculture for at least 10 generations in nutrient broth containing no drug.
Isolation of plasmid DNA for electron microscopy. Isolation of the Sa plasmid DNA followed the method described by Clowes (1) . Briefly, bacterial cells were harvested in late exponential phase and were lysed by ethylenediaminetetraacetate, lysozyme, and sodium dodecyl sulfate. Covalently closed circular form DNA was obtained by ethidium-CsCl density gradient centrifugation. Dialyzed DNA was mixed with 0.01% cytochrome c, spread as a monolayer, dried, and shadowed by platinum.
RESULTS
The resistance patterns of Shigella and E. coli strains to Tc, chloramphenicol (Cm), streptomycin (Sm), and Sa are shown in Table 1 . The isolation frequency of quadruply resistant strains was the highest, followed by singly, triply (Cm Sm Sa, Tc Sm Sa, Tc Cm Sa, and Tc (Table 2) .
We randomly selected from our stock cultures 25 Shigella and 23 E. coli strains possessing nonconjugative Sa resistance and examined them for the presence of plasmids encoding Sa resistance. A total of 18 Shigella strains (72%) and 13 E. coli strains (56.5%) lost their Sa resistance during storage or after treatment with acriflavine. These results strongly suggest that the determinant governing Sa resistance in Shigella and E. coli strains is most often located on a nonconjugative plasmid. To further examine the cytoplasmic inheritance of Sa resistance, we selected five E. coli and five Shigella strains, from which Sa resistance had been eliminated spontaneously or by treatment with acriflavine (see above). A transmissible Tc plasmid (Rms3O6) was conjugally transferred to each of these strains. As shown in Table 3 , the nonconjugative Sa resistance determinants were mobilized by the presence of the Rms3O6 plasmid, but the transconjugants that acquired only Sa resistance could not transfer their Sa resistance by conjugation. In contrast, the Sa Tc-resistant transconjugants were capable of transferring their Sa resistance, due to the concomitant presence of the conjugative Tc resistance plasmid. These results confirmed the presence of nonconjugative Sa plasmids in the Shigella and E. coli strains.
Contour length measurements. The nonconjugative Sa plasmids in Shigella and E. coli strains were transformed into E. coli C Rifr (Table 4) . Plasmid DNA was prepared for elec- a S medium containing sulfisoxazole (50 ,ug/ml) and nalidixic acid (50 jig/ml) was used for selection. Fig. 1 . Details of contour length measurements are shown in Table 5 .
The seven Sa plasmids were measured by electron microscopy and ranged from 1.79 to 2.08 ,um. DISCUSSION Conjugative resistance plasmids were first identified in Japan by the following properties (for a review, see reference 8): (i) transmission of resistance by mixed cultivation, (ii) interruption of the transmission with a fritted-glass disk to separate the two parental cultures, and (iii) spontaneous and induced loss of drug resistance from drug-resistant cells.
Nonconjugative resistance plasmids were discovered later in multiply resistant S. aureus strains by the irreversible loss of resistance and by genetic analysis of staphylococcal resistance (9) (10) (11) 13) . Since then, gram-negative host bacteria carrying nonconjugative plasmids have been found, and the multiple resistance of clinical isolates has been found to be due mostly to the presence of either conjugative or nonconjugative plasmids. The finding of nonconjugative plasmids gives us a useful tool for the pursuit of After the introduction of Sa and its derivatives into practical medicine, bacterial strains rapidly acquired Sa resistance and were isolated at a high frequency from clinical specimens (7) (8) (9) (10) . Thereafter, the wide use of antibiotics such as Tc, Cm, and Sm led to the emergence of multiply resistant strains in addition to Sa resistance. It is known that multiple antibiotic resistance in clinical isolates is due mostly to the presence of conjugative plasmids, resulting in the rapid spread of multiple resistance (8) .
It should be noted however that among strains singly resistant to Tc, Cm, Sm, or Sa, Sa-resistant strains were demonstrated most frequently in E. coli and Shigella strains. In contrast, the frequency of conjugative Sa plasmids is rather low in strains singly resistant to Sa.
The results described in this article have disclosed that nonconjugative Sa plasmids can be demonstrated at a high frequency in singly Saresistant E. coli and Shigella strains. The sizes of the Sa plasmids are found to be similar to those of nonconjugative plasmids in staphylococci. Most of the staphylococcal nonconjugative plasmids encode single resistance, and nonconjugative plasmids carrying multiple resistance are very few in number in staphylococci (9-11). It was found that Sa plasmids inE. coli and Shigella strains were all compatible with the standard R plasmids used for compatibility tests. The molecular weights of conjugative Sa plasmids ranged from 53 x 106 to 59 x 106, indicating a major difference between nonconjugative and conjugative Sa plasmids (4) .
